| Literature DB >> 31761325 |
Wuan-Geok Saw1, Chui-Fann Wong1, Thomas Dick2, Gerhard Grüber3.
Abstract
The F-ATP synthase is an essential enzyme in mycobacteria, including the pathogenic Mycobacterium tuberculosis. Several new compounds in the TB-drug pipeline target the F-ATP synthase. In light of the importance and pharmacological attractiveness of this novel antibiotic target, tools have to be developed to generate a recombinant mycobacterial F1FO ATP synthase to achieve atomic insight and mutants for mechanistic and regulatory understanding as well as structure-based drug design. Here, we report the first genetically engineered, purified and enzymatically active recombinant M. smegmatis F1FO ATP synthase. The projected 2D- and 3D structures of the recombinant enzyme derived from negatively stained electron micrographs are presented. Furthermore, the first 2D projections from cryo-electron images are revealed, paving the way for an atomic resolution structure determination.Entities:
Keywords: Bioenergetics; Drug discovery; Electron microscopy; F-ATP synthase; Mycobacterium; Tuberculosis
Mesh:
Substances:
Year: 2019 PMID: 31761325 DOI: 10.1016/j.bbrc.2019.11.098
Source DB: PubMed Journal: Biochem Biophys Res Commun ISSN: 0006-291X Impact factor: 3.575